Skip to main content
PMC home page
Sarcoma logoLink to Sarcoma
. 1999 Dec;3(3-4):157–165. doi: 10.1080/13577149977587

Hyper-Fractionated Radiotherapy for Soft Tissue Sarcoma: Results of the Second Study of Hyper-Fractionated Radiotherapy

R Jacob 1,4,✉, D Gilligan 2, M Robinson 3, C Harmer 1
PMCID: PMC2395427  PMID: 18521279

Abstract

Purpose and Method. Hyper-fractionated radiotherapy for treatment of soft tissue sarcomas is designed to deliver a higher total dose of radiation without an increase in late normal tissue damage. In a previous study at the Royal Marsden Hospital, a total dose of 75 Gy using twice daily 1.25 Gy fractions resulted in a higher incidence of late damage than conventional radiotherapy using 2 Gy daily fractions treating to a total of 60 Gy. The current trial therefore used a lower dose per fraction of 1.2 Gy and lower total dose of 72 Gy, with 60 fractions given over a period of 6 weeks.

Subjects. A total of 37 patients (22 males and 15 females) with a median age of 56 years (range 19–88 years) were treated.

Results. Of eight patients treated pre-operatively, six showed a partial response and in two the tumour was static. The maximum acute toxicities were grade 1 in eight, grade 2 in 14 and grade 3 in 15 patients. Late toxicities of the skin were graded 1 in 10 and grade 2 in nine patients. Five patients complained of pain in the irradiated bone and soft tissues, which was of moderate severity (grade 2). Stiffness was graded 2 in three patients and severe (grade 3) in one.Three patients had moderate and one patient had severe lymphoedema following treatment. The 5-year recurrence-free survival probability of patients treated radically was 76%. Following excision of local recurrences the study group had a disease-free survival probability of 86% at 5 years.

Discussion. The regime is well tolerated with comparable local control and late complication rates to standard daily fractionated therapy.The potential benefit of this regime needs to be defined in a prospective randomized trial.

Full Text

The Full Text of this article is available as a PDF (466.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbatucci J. S., Boulier N., de Ranieri J., Mandard A. M., Tanguy A., Busson A. Radiotherapy as an integrated part of the treatment of soft tissue sarcomas. Radiother Oncol. 1984 Aug;2(2):115–121. doi: 10.1016/s0167-8140(84)80047-x. [DOI] [PubMed] [Google Scholar]
  2. Barkley H. T., Jr, Martin R. G., Romsdahl M. M., Lindberg R., Zagars G. K. Treatment of soft tissue sarcomas by preoperative irradiation and conservative surgical resection. Int J Radiat Oncol Biol Phys. 1988 Apr;14(4):693–699. doi: 10.1016/0360-3016(88)90091-0. [DOI] [PubMed] [Google Scholar]
  3. Brennan M. F., Hilaris B., Shiu M. H., Lane J., Magill G., Friedrich C., Hajdu S. I. Local recurrence in adult soft-tissue sarcoma. A randomized trial of brachytherapy. Arch Surg. 1987 Nov;122(11):1289–1293. doi: 10.1001/archsurg.1987.01400230075014. [DOI] [PubMed] [Google Scholar]
  4. Carabell S. C., Goodman R. L. Radiation therapy for soft tissue sarcoma. Semin Oncol. 1981 Jun;8(2):201–206. [PubMed] [Google Scholar]
  5. Dunst J., Sauer R., Burgers J. M., Hawliczek R., Kürten R., Müller R. P., Wannenmacher M., Jürgens H. Radiotherapie beim Ewing-Sarkom: Aktuelle Ergebnisse der GPO-Studien CESS 81 und CESS 86. Klin Padiatr. 1988 May-Jun;200(3):261–266. doi: 10.1055/s-2008-1033718. [DOI] [PubMed] [Google Scholar]
  6. Eilber F. R., Mirra J. J., Grant T. T., Weisenburger T., Morton D. L. Is amputation necessary for sarcomas? A seven-year experience with limb salvage. Ann Surg. 1980;192(4):431–438. doi: 10.1097/00000658-198010000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Glaholm J., Harmer C. Soft-tissue sarcoma: neutrons versus photons for post-operative irradiation. Br J Radiol. 1988 Sep;61(729):829–834. doi: 10.1259/0007-1285-61-729-829. [DOI] [PubMed] [Google Scholar]
  8. Goffman T., Tochner Z., Glatstein E. Primary treatment of large and massive adult sarcomas with iododeoxyuridine and aggressive hyperfractionated irradiation. Cancer. 1991 Feb 1;67(3):572–576. doi: 10.1002/1097-0142(19910201)67:3<572::aid-cncr2820670308>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  9. Horiot J. C., Le Fur R., N'Guyen T., Chenal C., Schraub S., Alfonsi S., Gardani G., Van Den Bogaert W., Danczak S., Bolla M. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol. 1992 Dec;25(4):231–241. doi: 10.1016/0167-8140(92)90242-m. [DOI] [PubMed] [Google Scholar]
  10. Jereb B., Ghavimi F., Exelby P., Zang E. Local control of embryonal rhabdomyosarcoma in children by radiation therapy when combined with chemotherapy. Int J Radiat Oncol Biol Phys. 1980 Jul;6(7):827–833. doi: 10.1016/0360-3016(80)90319-3. [DOI] [PubMed] [Google Scholar]
  11. Jyothirmayi R., Sittampalam Y., Harmer C. Soft tissue sarcoma of the hand or foot: conservative surgery and radiotherapy. Sarcoma. 1999;3(1):17–24. doi: 10.1080/13577149977820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lindberg R. D., Martin R. G., Romsdahl M. M., Barkley H. T., Jr Conservative surgery and postoperative radiotherapy in 300 adults with soft-tissue sarcomas. Cancer. 1981 May 15;47(10):2391–2397. doi: 10.1002/1097-0142(19810515)47:10<2391::aid-cncr2820471012>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  13. Mandell L. R., Ghavimi F., Exelby P., Fuks Z. Preliminary results of alternating combination chemotherapy (CT) and hyperfractionated radiotherapy (HART) in advanced rhabdomyosarcoma (RMS). Int J Radiat Oncol Biol Phys. 1988 Jul;15(1):197–203. doi: 10.1016/0360-3016(88)90366-5. [DOI] [PubMed] [Google Scholar]
  14. Mandell L. R., Ghavimi F., Exelby P., Fuks Z. Preliminary results of alternating combination chemotherapy (CT) and hyperfractionated radiotherapy (HART) in advanced rhabdomyosarcoma (RMS). Int J Radiat Oncol Biol Phys. 1988 Jul;15(1):197–203. doi: 10.1016/0360-3016(88)90366-5. [DOI] [PubMed] [Google Scholar]
  15. Morton D. L., Eilber F. R., Townsend C. M., Jr, Grant T. T., Mirra J., Weisenburger T. H. Limb salvage from a multidisciplinary treatment approach for skeletal and soft tissue sarcomas of the extremity. Ann Surg. 1976 Sep;184(3):268–278. doi: 10.1097/00000658-197609000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Robinson M. H., Spruce L., Eeles R., Fryatt I., Harmer C. L., Thomas J. M., Westbury G. Limb function following conservation treatment of adult soft tissue sarcoma. Eur J Cancer. 1991;27(12):1567–1574. doi: 10.1016/0277-5379(91)90417-c. [DOI] [PubMed] [Google Scholar]
  17. Robinson M., Barr L., Fisher C., Fryatt I., Stotter A., Harmer C., Wiltshaw E., Westbury G. Treatment of extremity soft tissue sarcomas with surgery and radiotherapy. Radiother Oncol. 1990 Jul;18(3):221–233. doi: 10.1016/0167-8140(90)90058-5. [DOI] [PubMed] [Google Scholar]
  18. Robinson M., Cassoni A., Harmer C., Fisher C., Thomas J., Westbury G. High dose hyperfractionated radiotherapy in the treatment of extremity soft tissue sarcomas. Radiother Oncol. 1991 Oct;22(2):118–126. doi: 10.1016/0167-8140(91)90007-4. [DOI] [PubMed] [Google Scholar]
  19. Rosenberg S. A., Tepper J., Glatstein E., Costa J., Baker A., Brennan M., DeMoss E. V., Seipp C., Sindelar W. F., Sugarbaker P. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg. 1982 Sep;196(3):305–315. doi: 10.1097/00000658-198209000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Salinas R., Hussey D. H., Fletcher G. H., Lindberg R. D., Martin R. G., Peters L. J., Sinkovics J. G. Experience with neutron therapy for locally advanced sarcomas. Int J Radiat Oncol Biol Phys. 1980 Mar;6(3):267–272. doi: 10.1016/0360-3016(80)90132-7. [DOI] [PubMed] [Google Scholar]
  21. Schmitt G., Rassow J., Schnabel K., Bormann R., Bamberg M., Scherer E., Streffer C. Radiotherapy of soft tissue sarcomas with neutrons or a neutron boost. Br J Radiol. 1984 Mar;57(675):247–250. doi: 10.1259/0007-1285-57-675-247. [DOI] [PubMed] [Google Scholar]
  22. Shiu M. H., Turnbull A. D., Nori D., Hajdu S., Hilaris B. Control of locally advanced extremity soft tissue sarcomas by function-saving resection and brachytherapy. Cancer. 1984 Mar 15;53(6):1385–1392. doi: 10.1002/1097-0142(19840315)53:6<1385::aid-cncr2820530628>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  23. Simon M. A., Enneking W. F. The management of soft-tissue sarcomas of the extremities. J Bone Joint Surg Am. 1976 Apr;58(3):317–327. [PubMed] [Google Scholar]
  24. Slater J. D., McNeese M. D., Peters L. J. Radiation therapy for unresectable soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 1986 Oct;12(10):1729–1734. doi: 10.1016/0360-3016(86)90312-3. [DOI] [PubMed] [Google Scholar]
  25. Stuschke M., Thames H. D. Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials. Int J Radiat Oncol Biol Phys. 1997 Jan 15;37(2):259–267. doi: 10.1016/s0360-3016(96)00511-1. [DOI] [PubMed] [Google Scholar]
  26. Suit H. D., Proppe K. H., Mankin H. J., Wood W. C. Preoperative radiation therapy for sarcoma of soft tissue. Cancer. 1981 May 1;47(9):2269–2274. doi: 10.1002/1097-0142(19810501)47:9<2269::aid-cncr2820470928>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  27. Suit H. D., Russell W. O., Martin R. G. Sarcoma of soft tissue: clinical and histopathologic parameters and response to treatment. Cancer. 1975 May;35(5):1478–1483. doi: 10.1002/1097-0142(197505)35:5<1478::aid-cncr2820350537>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  28. Tanabe K. K., Pollock R. E., Ellis L. M., Murphy A., Sherman N., Romsdahl M. M. Influence of surgical margins on outcome in patients with preoperatively irradiated extremity soft tissue sarcomas. Cancer. 1994 Mar 15;73(6):1652–1659. doi: 10.1002/1097-0142(19940315)73:6<1652::aid-cncr2820730617>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  29. Tepper J. E., Suit H. D. Radiation therapy alone for sarcoma of soft tissue. Cancer. 1985 Aug 1;56(3):475–479. doi: 10.1002/1097-0142(19850801)56:3<475::aid-cncr2820560311>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  30. Willett C. G., Schiller A. L., Suit H. D., Mankin H. J., Rosenberg A. The histologic response of soft tissue sarcoma to radiation therapy. Cancer. 1987 Oct 1;60(7):1500–1504. doi: 10.1002/1097-0142(19871001)60:7<1500::aid-cncr2820600716>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  31. Williams M. V., Denekamp J., Fowler J. F. A review of alpha/beta ratios for experimental tumors: implications for clinical studies of altered fractionation. Int J Radiat Oncol Biol Phys. 1985 Jan;11(1):87–96. doi: 10.1016/0360-3016(85)90366-9. [DOI] [PubMed] [Google Scholar]
  32. Withers H. R., Peters L. J., Thames H. D., Fletcher G. H. Hyperfractionation. Int J Radiat Oncol Biol Phys. 1982 Oct;8(10):1807–1809. doi: 10.1016/0360-3016(82)90307-8. [DOI] [PubMed] [Google Scholar]

Articles from Sarcoma are provided here courtesy of Wiley

RESOURCES